Blood derivatives, Physicians' office, including specialists, Business services, nec, nec
Avant Immunotherapeutics
Avant Immunotherapeutics, located in Needham Heights, MA, is pioneering advancements in immunology with a focus on delivering transformative therapies for patients. Their lead program, barzolvolimab, is a humanized monoclonal antibody designed to target KIT, a key receptor involved in severe inflammatory, allergic, and autoimmune diseases.
Leveraging extensive expertise in developing antibody-based immunotherapies, Avant Immunotherapeutics utilizes robust in-house capabilities to optimize the discovery and development of innovative scientific programs. The company remains committed to improving patient outcomes through their advanced therapeutic approaches. Generated from the website